Please assess the completion status of the following clinical trial:

Trial Title: Methadone and Medication Abortion

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women requesting medication abortion up to 10 weeks gestation~* Fluent English speaking~* Able and willing to receive and send text messages and receive phone calls~* Opioid naive~* Healthy patients with no significant comorbidities~Exclusion Criteria:~* Any history of drug or alcohol use, opioid use in last 30 days, chronic use of pain medications, or use of benzodiazepines.~* Any chronic disease including renal, liver, respiratory or cardiac disease~* Any known allergies to mifepristone, misoprostol, nonsteroidal anti-inflammatory drugs (such as ibuprofen) and methadone.~* Known history of QT prolongation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Oral methadone (Type: EXPERIMENTAL): Participants will be given a preemptive analgesic in addition to a standard dose of ibuprofen while undergoing early medication abortion with mifepristone and misoprostol (not provided as part of the study). All participants will also be provided with supplementary non- opioid analgesics to be used at their own discretion during the process.

Based on this trial design, predict the completion outcome and termination type (if applicable).